Join the DDA or

May shortages update published

18 new supply issues identified

May 10th 2019

Tagged: Clinical Zone news supply shortages

By Ailsa Colquhoun

The Department of Health and Social Care has published its supply issues update for primary and secondary care for May 2019.

This covers new and ongoing shortages. DDA members can view the detail of the shortages by visiting the Clinical Zone

New shortages are reported as follows:


  • Ancotil (flucytosine) injection
  • Arsenic acid
  • Midazolam injection
  • Pentamidine 300mg in 5mL injection


  • Cycloserine 250mg capsules
  • Epanutin (phenytoin) 50mg Chewable Infatabs
  • Labetalol tablets
  • Methadone 1mg/ml oral solution sugar free
  • Qlaira tablets
  • Questran Powder for Oral Suspension/Questran Light (colestyramine) 4g sachets
  • Rifadin (rifampicin) 300mg capsules
  • Sabril (vigabatrin) tablets
  • Sinemet (co-careldopa) tablets
  • Thorens (colecalciferol) 10,000i.u./ml oral drops
  • Xanax (alprazolam) tablets
  • Zolmitriptan 2.5mg orodispersible tablets
  • Loestrin 20 and Loestrin 30 tablets

Eye drops/treatments  

  • Iopidine (apraclonidine hydrochloride) 0.5% eye drops